مؤتمر
أعرض في EDS

599P R-IMMUNE: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with locally advanced rectal cancer (LARC)

التفاصيل البيبلوغرافية
العنوان: 599P R-IMMUNE: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with locally advanced rectal cancer (LARC)
المؤلفون: Carrasco, Javier, Beniuga, Gabriela, Mourin, Anne, Baldin, Paméla, Sinapi, Isabelle, Schroeder, David, De Cuyper, Astrid, Sclafani, Francesco, Hendlisz, Alain, van Laethem, Jean-Luc, Boulanger, Anne-Sophie, Van Ooteghem, Geneviève, Dermine, Alexandre, Delmarcelle, Sophie, Huyghe, Nicolas, Bar, Isabelle, Van den Eynde, Marc, ESMO Congress 2023
المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - SSS/IREC/MORF - Pôle de Morphologie, UCL - (SLuc) Service d'anatomie pathologique, UCL - (SLuc) Service d'oncologie médicale, UCL - (SLuc) Service de radiothérapie oncologique, UCL - (SLuc) Centre du cancer
المصدر: Annals of Oncology, Vol. 34, no.Suppl 1, p. S432 (2023)
بيانات النشر: Elsevier
سنة النشر: 2023
المجموعة: DIAL@USL-B (Université Saint-Louis, Bruxelles)
مصطلحات موضوعية: Oncology, Hematology
الوصف: BACKGROUND : There is a strong rationale to combine radiotherapy with immune checkpoint inhibitors (ICIs). This study evaluates this combination before surgery in locally advanced rectal cancer (LARC). [.]
نوع الوثيقة: conference object
اللغة: English
تدمد: 0923-7534
1569-8041
العلاقة: boreal:285081; http://hdl.handle.net/2078.1/285081Test; urn:ISSN:0923-7534; urn:EISSN:1569-8041
DOI: 10.1016/j.annonc.2023.09.1790
الإتاحة: https://doi.org/10.1016/j.annonc.2023.09.1790Test
http://hdl.handle.net/2078.1/285081Test
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.F74C6B73
قاعدة البيانات: BASE
الوصف
تدمد:09237534
15698041
DOI:10.1016/j.annonc.2023.09.1790